Literature DB >> 15798432

Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.

Pearl E Grimes1, Nanaka Yamada, Jag Bhawan.   

Abstract

Despite new technologies, few studies have assessed the histologic alterations in patients with melasma. Using current technologies, the present study was designed to re-evaluate the light microscopic, immunohistochemical, and ultrastructural changes of the hyperpigmented and adjacent normal skin of patients with melasma. Twenty-one patients were included in this study. Two millimeter punch biopsies were taken from the hyperpigmented and adjacent normal skin of the face. The integrity of the epidermis and dermis was assessed by light microscopy, computer-assisted image analysis, immunohistochemistry, and electron microscopy. Stains included hematoxylin-eosin and Fontana-Masson for melanin detection. Immunostaining was performed using Mel-5 antibody and CD1a antibody as markers for melanin and Langerhans cells, respectively. However, mild lymphohistiocytic infiltrates were present in 75% of the hyperpigmented areas. The areas of hyperpigmentation showed increased deposition of melanin in the epidermis and dermis of all cases. There was a statistically significant increase in the content of epidermal melanin. There were no quantitative increases in melanocytes in the hyperpigmented areas of skin. However, the melanocytes in the hyperpigmented areas were larger, intensely stained cells with very prominent dendrites. Electron microscopy revealed more melanosomes in keratinocytes, melanocytes, and dendrites in the involved skin in comparison to the uninvolved skin. The results of this study suggest that melasma is a consequence of specific hyperfunctional melanocytes that cause excessive melanin deposition in the epidermis and dermis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798432     DOI: 10.1097/01.dad.0000154419.18653.2e

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  27 in total

1.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  In vivo multiphoton microscopy of melasma.

Authors:  Griffin Lentsch; Mihaela Balu; Joshua Williams; Sanghoon Lee; Ronald M Harris; Karsten König; Anand Ganesan; Bruce J Tromberg; Nirmala Nair; Uma Santhanam; Manoj Misra
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-21       Impact factor: 4.693

3.  Melasma and laser treatment: an evidenced-based analysis.

Authors:  Shlomit Halachmi; Merete Haedersdal; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-06-14       Impact factor: 3.161

Review 4.  [Melasma : An update on the clinical picture, treatment, and prevention].

Authors:  S Becker; C Schiekofer; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

5.  Anatomical and histological study to determine the border of sole skin.

Authors:  Noriko Uemura; Mutsumi Okazaki; Hiroki Mori
Journal:  Surg Radiol Anat       Date:  2016-01-02       Impact factor: 1.246

6.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 7.  Associations between environmental factors and incidence of cutaneous melanoma. Review.

Authors:  Katarina Volkovova; Dagmar Bilanicova; Alena Bartonova; Silvia Letašiová; Maria Dusinska
Journal:  Environ Health       Date:  2012-06-28       Impact factor: 5.984

8.  Topical treatment of melasma.

Authors:  Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

9.  A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients.

Authors:  Charu Bansal; Hira Naik; Hemanta K Kar; Amrita Chauhan
Journal:  J Cutan Aesthet Surg       Date:  2012-10

10.  Chemical peels for melasma in dark-skinned patients.

Authors:  Rashmi Sarkar; Shuchi Bansal; Vijay K Garg
Journal:  J Cutan Aesthet Surg       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.